Hypertensive disorders in pregnancy (HDP) are associated with an increased risk of cardiomyopathy years after an affected pregnancy and regardless of hypertension severity, a large registry study involving one million Danish women shows. “The fact that we could drop the first 5 years after pregnancy and still see this risk was really fascinating,” senior author […]
Read MoreThe toll that opioid addiction has taken in the United States is staggering, said Jesse Theisen-Toupal, MD, from the Veterans Administration Medical Center in Washington, DC. “In 2000, there were 4400 opioid overdose-related deaths,” he reported here at the Society of Hospital Medicine 2016 Annual Meeting. “In 2013, there were 16,000.” Despite this crisis, some […]
Read MoreContrary to expectations, smoking and obesity do not appear to affect the efficacy of, or increase the infection rate related to, spinal cord stimulator implantation, a new study shows. “It’s very well known that smoking, for example, can increase the risk of infection and of complications in different types of major surgery, especially spinal surgery,” […]
Read MoreA peripherally acting oral μ-opioid receptor antagonist is superior to placebo in treating opioid-induced constipation (OIC) and doesn’t reduce the analgesic effect of opioids, a new phase 3 study shows. If approved, the new drug, naldemedine (Shionogi Inc), will provide another option for physicians and patients to treat OIC, which is common in patients taking […]
Read MoreAs opioid-related deaths across the country skyrocket, more and more state, national, and international groups are calling for widespread community access to naloxone, a drug that reverses opioid overdose. While naloxone has traditionally been administered in a hospital or medical setting by trained emergency responders, the drug is now available as a “take-home” product that […]
Read More